Ano1 is a Prognostic Biomarker That is Correlated with Immune Infiltration in Colorectal Cancer

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Yang Y, Han Z, Li X, Huang A, Shi J, Gu J. Epidemiology and risk factors of colorectal cancer in China. Chin J Cancer Res. 2020;32(6):729–741. doi:10.21147/j.issn.1000-9604.2020.06.06
   PubMed Web of Science ®Google Scholar
• Tricoli JV, Boardman LA, Patidar R, et al. A mutational comparison of adult and adolescent and young adult (AYA) colon cancer. Cancer. 2018;124(5):1070–1082. doi:10.1002/cncr.31136
   PubMed Web of Science ®Google Scholar
• Wasan HS, Gibbs P, Sharma NK, et al. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-global): a combined analysis of three multicentre, randomised, Phase 3 trials. Lancet Oncol. 2017;18(9):1159–1171. doi:10.1016/S1470-2045(17)30457-6
   PubMed Web of Science ®Google Scholar
• Wookey V, Grothey A. Update on the role of pembrolizumab in patients with unresectable or metastatic colorectal cancer. Therap Adv Gastroenterol. 2021;14:17562848211024460. doi:10.1177/17562848211024460
   Web of Science ®Google Scholar
• Nguyen M, Tipping Smith SS, Lam M, et al. An update on the use of immunotherapy in patients with colorectal cancer. Expert Rev Gastroenterol Hepatol. 2021;15(3):291–304. doi:10.1080/17474124.2021.1845141
   PubMed Web of Science ®Google Scholar
• Jansen K, Büscheck F, Moeller K, et al. DOG1 is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressiveness. PeerJ. 2021;9:e11905. doi:10.7717/peerj.11905
   PubMed Web of Science ®Google Scholar
• Duvvuri U, Shiwarski DJ, Xiao D, et al. TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression. Cancer Res. 2012;72(13):3270–3281. doi:10.1158/0008-5472.Can-12-0475-t
   PubMed Web of Science ®Google Scholar
• Kashyap MK, Marimuthu A, Kishore CJ, et al. Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers. Cancer Biol Ther. 2009;8(1):36–46. doi:10.4161/cbt.8.1.7090
   PubMed Web of Science ®Google Scholar
• Benedetto R, Cabrita I, Schreiber R, Kunzelmann K. TMEM16A is indispensable for basal mucus secretion in airways and intestine. FASEB J. 2019;33(3):4502–4512. doi:10.1096/fj.201801333RRR
   PubMed Web of Science ®Google Scholar
• Peters CJ, Gilchrist JM, Tien J, et al. The sixth transmembrane segment is a major gating component of the TMEM16A calcium-activated chloride channel. Neuron. 2018;97(5):1063–1077.e1064. doi:10.1016/j.neuron.2018.01.048
   PubMed Web of Science ®Google Scholar
• Filippou A, Pehkonen H, Karhemo PR, et al. ANO1 expression orchestrates p27Kip1/MCL1-mediated signaling in head and neck squamous cell carcinoma. Cancers. 2021;13:5. doi:10.3390/cancers13051170
   Web of Science ®Google Scholar
• Song Y, Gao J, Guan L, Chen X, Gao J, Wang K. Inhibition of ANO1/TMEM16A induces apoptosis in human prostate carcinoma cells by activating TNF-α signaling. Cell Death Dis. 2018;9(6):703. doi:10.1038/s41419-018-0735-2
   PubMed Web of Science ®Google Scholar
• Nishida T, Sakai Y, Takagi M, et al. Adherence to the guidelines and the pathological diagnosis of high-risk gastrointestinal stromal tumors in the real world. Gastric Cancer. 2020;23(1):118–125. doi:10.1007/s10120-019-00966-4
   PubMed Web of Science ®Google Scholar
• Wang H, Yao F, Luo S, et al. A mutual activation loop between the Ca(2+)-activated chloride channel TMEM16A and EGFR/STAT3 signaling promotes breast cancer tumorigenesis. Cancer Lett. 2019;455:48–59. doi:10.1016/j.canlet.2019.04.027
   PubMed Web of Science ®Google Scholar
• Zhang C, Li H, Gao J, Cui X, Yang S, Liu Z. Prognostic significance of ANO1 expression in cancers. Medicine. 2021;100(4):e24525. doi:10.1097/md.0000000000024525
   PubMed Web of Science ®Google Scholar
• Jiang Y, Cai Y, Shao W, et al. MicroRNA-144 suppresses aggressive phenotypes of tumor cells by targeting ANO1 in colorectal cancer. Oncol Rep. 2019;41(4):2361–2370. doi:10.3892/or.2019.7025
   PubMed Web of Science ®Google Scholar
• Colaprico A, Silva TC, Olsen C, et al. TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71. doi:10.1093/nar/gkv1507
   PubMed Web of Science ®Google Scholar
• Law CW, Alhamdoosh M, Su S, et al. RNA-seq analysis is easy as 1-2-3 with limma, glimma and edgeR. F1000Research. 2016;5:1408. doi:10.12688/f1000research.9005.3
   Google Scholar
• Liberzon A, Birger C, Thorvaldsdóttir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417–425. doi:10.1016/j.cels.2015.12.004
   PubMed Web of Science ®Google Scholar
• Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7. doi:10.1186/1471-2105-14-7
   PubMed Web of Science ®Google Scholar
• Tang Y, Li M, Wang J, Pan Y, Wu FX. CytoNCA: a Cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Bio Systems. 2015;127:67–72. doi:10.1016/j.biosystems.2014.11.005
   PubMed Web of Science ®Google Scholar
• He X, Zhang J. Why do hubs tend to be essential in protein networks? PLoS Genet. 2006;2(6):e88. doi:10.1371/journal.pgen.0020088
   PubMed Web of Science ®Google Scholar
• Newman AM, Steen CB, Liu CL, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37(7):773–782. doi:10.1038/s41587-019-0114-2
   PubMed Web of Science ®Google Scholar
• Villanueva A, Portela A, Sayols S, et al. DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma. Hepatology. 2015;61(6):1945–1956. doi:10.1002/hep.27732
   PubMed Web of Science ®Google Scholar
• Aparicio T, Bouche O, Taieb J, et al. Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized Phase II trial-PRODIGE 20 study results. Ann Oncol. 2018;29(1):133–138. doi:10.1093/annonc/mdx529
   PubMed Web of Science ®Google Scholar
• de Andrea CE, Schalper KA, Sanmamed MF, Melero I. Immunodivergence in metastatic colorectal cancer. Cancer Cell. 2018;34(6):876–878. doi:10.1016/j.ccell.2018.11.012
   PubMed Web of Science ®Google Scholar
• Sun W, Nie W, Wang Z, Zhang H, Li Y, Fang X. Lnc HAGLR promotes colon cancer progression through sponging miR-185-5p and activating CDK4 and CDK6 in vitro and in vivo. Onco Targets Ther. 2020;13:5913–5925. doi:10.2147/OTT.S246092
   PubMed Web of Science ®Google Scholar
• Lu H, Shi T, Wang M, et al. B7-H3 inhibits the IFN-γ-dependent cytotoxicity of Vγ9Vδ2 T cells against colon cancer cells. Oncoimmunology. 2020;9(1):1748991. doi:10.1080/2162402X.2020.1748991
   PubMed Web of Science ®Google Scholar
• Malonis RJ, Lai JR, Vergnolle O. Peptide-based vaccines: current progress and future challenges. Chem Rev. 2020;120(6):3210–3229. doi:10.1021/acs.chemrev.9b00472
   PubMed Web of Science ®Google Scholar
• Lin H, Wang B, Yu J, Wang J, Li Q, Cao B. Protein arginine methyltransferase 8 gene enhances the colon cancer stem cell (CSC) function by upregulating the pluripotency transcription factor. J Cancer. 2018;9(8):1394–1402. doi:10.7150/jca.23835
   PubMed Web of Science ®Google Scholar
• Angelbello AJ, Chen JL, Childs-Disney JL, Zhang P, Wang Z-F, Disney MD. Using genome sequence to enable the design of medicines and chemical probes. Chem Rev. 2018;118(4):1599–1663. doi:10.1021/acs.chemrev.7b00504
   PubMed Web of Science ®Google Scholar
• Woolston A, Khan K, Spain G, et al. Genomic and transcriptomic determinants of therapy resistance and immune landscape evolution during anti-EGFR treatment in colorectal cancer. Cancer Cell. 2019;36(1):35–50.e39. doi:10.1016/j.ccell.2019.05.013
   PubMed Web of Science ®Google Scholar
• Azad T, Janse van Rensburg HJ, Lightbody ED, et al. A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis. Nat Commun. 2018;9(1):1061. doi:10.1038/s41467-018-03278-w
   PubMed Web of Science ®Google Scholar
• Zhang Y-F, Li C-S, Zhou Y, Lu X-H. Effects of propofol on colon cancer metastasis through STAT3/HOTAIR axis by activating WIF-1 and suppressing Wnt pathway. Cancer Med. 2020;9(5):1842–1854. doi:10.1002/cam4.2840
   PubMed Web of Science ®Google Scholar
• Liu JJ, He F, Guo SB. TMEM16A overexpression indicates poor prognosis in colorectal cancer patients. Rev Esp Enferm Dig. 2021. doi:10.17235/reed.2021.8292/2021
   Web of Science ®Google Scholar
• Mokutani Y, Uemura M, Munakata K, et al. Down-regulation of microRNA-132 is associated with poor prognosis of colorectal cancer. Ann Surg Oncol. 2016;23(Suppl5):599–608. doi:10.1245/s10434-016-5133-3
   PubMed Web of Science ®Google Scholar
• Fukusumi T, Guo TW, Sakai A, et al. The NOTCH4-HEY1 pathway induces epithelial-mesenchymal transition in head and neck squamous cell carcinoma. Clin Cancer Res. 2018;24(3):619–633. doi:10.1158/1078-0432.CCR-17-1366
   PubMed Web of Science ®Google Scholar
• Xue J, Li R, Gao D, Chen F, Xie H. CXCL12/CXCR4 axis-targeted dual-functional nano-drug delivery system against ovarian cancer. Int J Nanomedicine. 2020;15:5701–5718. doi:10.2147/IJN.S257527
   PubMed Web of Science ®Google Scholar
• Zhang L-M, Wang P, Liu X-M, Zhang Y-J. LncRNA SUMO1P3 drives colon cancer growth, metastasis and angiogenesis. Am J Transl Res. 2017;9(12):5461–5472.
   PubMed Web of Science ®Google Scholar
• Li J, Byrne KT, Yan F, et al. Tumor cell-intrinsic factors underlie heterogeneity of immune cell infiltration and response to immunotherapy. Immunity. 2018;49(1):178–193.e177. doi:10.1016/j.immuni.2018.06.006
   PubMed Web of Science ®Google Scholar